{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:51:43Z","timestamp":1792785103695,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012336","name":"Major State Basic Research Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1303800 and 2021 YFA1301300"],"award-info":[{"award-number":["2022YFA1303800 and 2021 YFA1301300"]}],"id":[{"id":"10.13039\/501100012336","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Natural Science Foundation of China","award":["82373946,82073926,82321005,82530122,and 81930109"],"award-info":[{"award-number":["82373946,82073926,82321005,82530122,and 81930109"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Major Science and Technology Project of Jiangsu Province","award":["BG2024045"],"award-info":[{"award-number":["BG2024045"]}]},{"DOI":"10.13039\/501100013313","name":"111 Plan | Overseas Expertise Introduction Project for Discipline Innovation","doi-asserted-by":"publisher","award":["G20582017001"],"award-info":[{"award-number":["G20582017001"]}],"id":[{"id":"10.13039\/501100013313","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Project of State Key Laboratory of Natural Medicines, China Pharmaceutical University","award":["SKLNMZZ202402"],"award-info":[{"award-number":["SKLNMZZ202402"]}],"id":[{"id":"https:\/\/ror.org\/01as92r37","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Project Program of Basic Science Research Center Base of Yantai Uniiversity","award":["P202404"],"award-info":[{"award-number":["P202404"]}]},{"name":"Fundamental and Interdisciplinary Disciplines Breakthrough Plan of the Ministry of Education of China","award":["JYB2025XDXM601"],"award-info":[{"award-number":["JYB2025XDXM601"]}],"id":[{"id":"https:\/\/ror.org\/03m01yf64","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Obesity is a chronic condition and is closely associated with various metabolic diseases. It has become a global health concern, and effective pharmacotherapies are urgently needed. Farnesoid X receptor (FXR) is widely regarded as a pivotal target for the treatment of metabolic diseases because of its many biological functions. To avoid the possible adverse side effects of systemic FXR agonism, intestinal-specific FXR agonists have been developed. They show excellent anti-obesity effects, but the underlying mechanism remains unclear. In this study, we demonstrate that intestinal-restricted FXR agonists exhibit marked anti-obesity effects in diet-induced obesity (DIO) and db\/db mice, but not in ob\/ob mice. Mechanistically, they suppress appetite to reduce obesity in leptin-dependent and secretin-dependent manners. Intestinal FXR agonism upregulates secretin (SCT) expression in the presence of leptin. Specifically, FXR agonism enhances histone H3K4 methylation at the\n                    <jats:italic>Sct<\/jats:italic>\n                    locus, while leptin per se suppresses DNA methylation at the same locus in a leptin-receptor independent manner. Collectively, the results of this study clarify the anti-obesity mechanism underlying intestinal FXR agonists.\n                  <\/jats:p>","DOI":"10.1038\/s44319-026-00938-7","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:41:02Z","timestamp":1791193262000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intestinal FXR agonism synergizes with leptin to improve obesity by reducing appetite via secretin"],"prefix":"10.1038","author":[{"given":"Xiaochai","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1165-4525","authenticated-orcid":false,"given":"Jingru","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maosheng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1886-2728","authenticated-orcid":false,"given":"Xiaowei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2522-7546","authenticated-orcid":false,"given":"Haiping","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6192-3082","authenticated-orcid":false,"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"938_CR1","doi-asserted-by":"publisher","first-page":"G771","DOI":"10.1152\/ajpgi.00499.2010","volume":"300","author":"M Ananthanarayanan","year":"2011","unstructured":"Ananthanarayanan M, Li Y, Surapureddi S, Balasubramaniyan N, Ahn J, Goldstein JA, Suchy FJ (2011) Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis. Am J Physiol Gastrointest Liver Physiol 300:G771\u2013G781","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"938_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1534\/genetics.117.300536","volume":"208","author":"WT Barrington","year":"2018","unstructured":"Barrington WT, Wulfridge P, Wells AE, Rojas CM, Howe SYF, Perry A, Hua K, Pellizzon MA, Hansen KD, Voy BH et al (2018) Improving metabolic health through precision dietetics in mice. Genetics 208:399\u2013417","journal-title":"Genetics"},{"key":"938_CR3","doi-asserted-by":"publisher","DOI":"10.48130\/targetome-0025-0009","volume":"1","author":"A Chen","year":"2025","unstructured":"Chen A, Zhu X, Jiang H, Gong M, Cui S, Wang G, Wang H, Hao H (2025) Combination of silybin and carvedilol synergistically alleviates liver fibrosis by inhibiting Wnt\/\u03b2-catenin signaling. Targetome 1:e009","journal-title":"Targetome"},{"key":"938_CR4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.apsb.2022.08.019","volume":"13","author":"S Cui","year":"2022","unstructured":"Cui S, Hu H, Chen A, Cui M, Pan X, Zhang P, Wang G, Wang H, Hao H (2022) SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXR. Acta Pharm Sin B 13:559\u2013576","journal-title":"Acta Pharm Sin B"},{"key":"938_CR5","first-page":"401","volume":"19","author":"S Cui","year":"2021","unstructured":"Cui S, Pan X, Ge C, Guo Y, Zhang P, Yan T, Zhou J, He Q, Cheng L, Wang G et al (2021) Silybin alleviates hepatic lipid accumulation in methionine-choline deficient diet-induced nonalcoholic fatty liver disease in mice via peroxisome proliferator-activated receptor \u03b1. Chin J Nat Med 19:401\u2013411","journal-title":"Chin J Nat Med"},{"key":"938_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41591-019-0358-x","volume":"25","author":"X Feng","year":"2019","unstructured":"Feng X, Guan D, Auen T, Choi JW, Salazar Hern\u00e1ndez MA, Lee J, Chun H, Faruk F, Kaplun E, Herbert Z et al (2019) IL1R1 is required for celastrol\u2019s leptin-sensitization and antiobesity effects. Nat Med 25:575\u2013582","journal-title":"Nat Med"},{"key":"938_CR7","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s42255-019-0074-3","volume":"1","author":"RM Gadaleta","year":"2019","unstructured":"Gadaleta RM, Moschetta A (2019) Metabolic messengers: fibroblast growth factor 15\/19. Nat Metab 1:588\u2013594","journal-title":"Nat Metab"},{"key":"938_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13578-023-00955-2","volume":"13","author":"A Huang","year":"2023","unstructured":"Huang A, Maier MT, Vagena E, Xu AW (2023) Modulation of foraging-like behaviors by cholesterol-FGF19 axis. Cell Biosci 13:20","journal-title":"Cell Biosci"},{"key":"938_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12896-x","volume":"10","author":"F Huang","year":"2019","unstructured":"Huang F, Zheng X, Ma X, Jiang R, Zhou W, Zhou S, Zhang Y, Lei S, Wang S, Kuang J et al (2019) Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism. Nat Commun 10:4971","journal-title":"Nat Commun"},{"key":"938_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.107071","volume":"143","author":"W Huang","year":"2024","unstructured":"Huang W, Cao Z, Wang W, Yang Z, Jiao S, Chen Y, Chen S, Zhang L, Li Z (2024) Discovery of LH10, a novel fexaramine-based FXR agonist for the treatment of liver disease. Bioorg Chem 143:107071","journal-title":"Bioorg Chem"},{"key":"938_CR11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.tem.2004.09.010","volume":"15","author":"RG Hunter","year":"2004","unstructured":"Hunter RG, Philpot K, Vicentic A, Dominguez G, Hubert GW, Kuhar MJ (2004) CART in feeding and obesity. Trends Endocrinol Metab 15:454\u2013459","journal-title":"Trends Endocrinol Metab"},{"key":"938_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155937","volume":"157","author":"M Huttasch","year":"2024","unstructured":"Huttasch M, Roden M, Kahl S (2024) Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease? Metabolism 157:155937","journal-title":"Metabolism"},{"key":"938_CR13","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1161\/CIRCRESAHA.110.225326","volume":"107","author":"H Iwasaki","year":"2010","unstructured":"Iwasaki H, Kovacic JC, Olive M, Beers JK, Yoshimoto T, Crook MF, Tonelli LH, Nabel EG (2010) Disruption of protein arginine N-methyltransferase 2 regulates leptin signaling and produces leanness in vivo through loss of STAT3 methylation. Circ Res 107:992\u20131001","journal-title":"Circ Res"},{"key":"938_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng1089","volume":"33","author":"R Jaenisch","year":"2003","unstructured":"Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33:245\u2013254","journal-title":"Nat Genet"},{"key":"938_CR15","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1210\/me.2009-0099","volume":"23","author":"DH Kim","year":"2009","unstructured":"Kim DH, Lee J, Lee B, Lee JW (2009) ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity. Mol Endocrinol 23:1556\u20131562","journal-title":"Mol Endocrinol"},{"key":"938_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19803-9","volume":"11","author":"YC Kim","year":"2020","unstructured":"Kim YC, Seok S, Zhang Y, Ma J, Kong B, Guo G, Kemper B, Kemper JK (2020) Intestinal FGF15\/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A. Nat Commun 11:5969","journal-title":"Nat Commun"},{"key":"938_CR17","volume":"2023","author":"G Kov\u00e1cs","year":"2023","unstructured":"Kov\u00e1cs G, Mohos E, Kis JT, Tab\u00e1k \u00c1, Gerendy P, Pettk\u00f3 J, Nagy D, Gy\u0151rb\u00edr\u00f3 D, Kal\u00f3 Z (2023) Cost-effectiveness of bariatric surgery in patients living with obesity and type 2 diabetes. J Diab Res 2023:9686729","journal-title":"J Diab Res"},{"key":"938_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/29993","volume":"393","author":"P Kristensen","year":"1998","unstructured":"Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N et al (1998) Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393:72\u201376","journal-title":"Nature"},{"key":"938_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28268-x","volume":"13","author":"O Kubrak","year":"2022","unstructured":"Kubrak O, Koyama T, Ahrentl\u00f8v N, Jensen L, Malita A, Naseem MT, Lassen M, Nagy S, Texada MJ, Halberg KV et al (2022) The gut hormone Allatostatin C\/Somatostatin regulates food intake and metabolic homeostasis under nutrient stress. Nat Commun 13:692","journal-title":"Nat Commun"},{"key":"938_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.737686","volume":"12","author":"S Laurila","year":"2021","unstructured":"Laurila S, Rebelos E, Honka MJ, Nuutila P (2021) Pleiotropic effects of secretin: a potential drug candidate in the treatment of obesity? Front Endocrinol 12:737686","journal-title":"Front Endocrinol"},{"key":"938_CR21","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nm.4145","volume":"22","author":"J Lee","year":"2016","unstructured":"Lee J, Liu J, Feng X, Salazar Hern\u00e1ndez MA, Mucka P, Ibi D, Choi JW, Ozcan U (2016) Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice. Nat Med 22:1023\u20131032","journal-title":"Nat Med"},{"key":"938_CR22","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1210\/me.2003-0461","volume":"18","author":"LT Lee","year":"2004","unstructured":"Lee LT, Tan-Un KC, Pang RT, Lam DT, Chow BK (2004) Regulation of the human secretin gene is controlled by the combined effects of CpG methylation, Sp1\/Sp3 ratio, and the E-box element. Mol Endocrinol 18:1740\u20131755","journal-title":"Mol Endocrinol"},{"key":"938_CR23","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.cell.2013.02.014","volume":"152","author":"TI Lee","year":"2013","unstructured":"Lee TI, Young RA (2013) Transcriptional regulation and its misregulation in disease. Cell 152:1237\u20131251","journal-title":"Cell"},{"key":"938_CR24","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1152\/physrev.00002.2024","volume":"105","author":"BE Levin","year":"2025","unstructured":"Levin BE, Geary N, Lutz TA (2025) The (dys)regulation of energy storage in obesity. Physiol Rev 105:803\u2013895","journal-title":"Physiol Rev"},{"key":"938_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3384","volume":"4","author":"F Li","year":"2013","unstructured":"Li F, Jiang C, Krausz KW, Li Y, Albert I, Hao H, Fabre KM, Mitchell JB, Patterson AD, Gonzalez FJ (2013) Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat Commun 4:2384","journal-title":"Nat Commun"},{"key":"938_CR26","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2015.05.011","volume":"161","author":"J Liu","year":"2015","unstructured":"Liu J, Lee J, Salazar Hernandez MA, Mazitschek R, Ozcan U (2015) Treatment of obesity with celastrol. Cell 161:999\u20131011","journal-title":"Cell"},{"key":"938_CR27","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1126\/sciadv.add5330","volume":"9","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wei JA, Luo Z, Cui J, Luo Y, Mak SOK, Wang S, Zhang F, Yang Y, So KF et al (2023) A gut-brain axis mediates sodium appetite via gastrointestinal peptide regulation on a medulla-hypothalamic circuit. Sci Adv 9:5330","journal-title":"Sci Adv"},{"key":"938_CR28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1053\/j.gastro.2011.10.028","volume":"142","author":"S Modica","year":"2012","unstructured":"Modica S, Petruzzelli M, Bellafante E, Murzilli S, Salvatore L, Celli N, Di Tullio G, Palasciano G, Moustafa T, Halilbasic E et al (2012) Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis. Gastroenterology 142:355\u2013365","journal-title":"Gastroenterology"},{"key":"938_CR29","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.cell.2018.11.008","volume":"175","author":"RL Mynatt","year":"2018","unstructured":"Mynatt RL, Ravussin E (2018) Secretin: an old hormone with a burning secret. Cell 175:1459\u20131460","journal-title":"Cell"},{"key":"938_CR30","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/hep.29857","volume":"68","author":"P Pathak","year":"2018","unstructured":"Pathak P, Xie C, Nichols RG, Ferrell JM, Boehme S, Krausz KW, Patterson AD, Gonzalez FJ, Chiang JYL (2018) Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism. Hepatology 68:1574\u20131588","journal-title":"Hepatology"},{"key":"938_CR31","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0140-6736(22)02403-5","volume":"401","author":"CM Perdomo","year":"2023","unstructured":"Perdomo CM, Cohen RV, Sumithran P, Cl\u00e9ment K, Fr\u00fchbeck G (2023) Contemporary medical, device, and surgical therapies for obesity in adults. Lancet 401:1116\u20131130","journal-title":"Lancet"},{"issue":"11","key":"938_CR32","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.120.316101","volume":"126","author":"ME Pich\u00e9","year":"2020","unstructured":"Pich\u00e9 ME, Tchernof A, Despr\u00e9s JP (2020) Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res 126(11):1477\u20131500","journal-title":"Circ Res"},{"key":"938_CR33","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1172\/JCI37273","volume":"119","author":"M Qatanani","year":"2009","unstructured":"Qatanani M, Szwergold NR, Greaves DR, Ahima RS, Lazar MA (2009) Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. J Clin Invest 119:531\u2013539","journal-title":"J Clin Invest"},{"key":"938_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2025.109994","volume":"144","author":"AM Rodr\u00edguez","year":"2025","unstructured":"Rodr\u00edguez AM, Asnani-Kishnani M, Yau-Qiu ZX, Galm\u00e9s S, Palou A (2025) Perinatal leptin effects on hypothalamic brain-derived neurotrophic factor and energy balance-related gene regulation. J Nutr Biochem 144:109994","journal-title":"J Nutr Biochem"},{"key":"938_CR35","doi-asserted-by":"crossref","unstructured":"Rubino DM, Greenway FL, Khalid U, O\u2019Neil PM, Rosenstock J, S\u00f8rrig R, Wadden TA, Wizert A, Garvey WT, STEP 8 Investigators (2022) Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial. JAMA 327:138\u2013150","DOI":"10.1001\/jama.2021.23619"},{"issue":"8","key":"938_CR36","doi-asserted-by":"publisher","first-page":"e2423385","DOI":"10.1001\/jamanetworkopen.2024.23385","volume":"7","author":"G Schoretsanitis","year":"2024","unstructured":"Schoretsanitis G, Weiler S, Barbui C, Raschi E, Gastaldon C (2024) Disproportionality analysis from world health organization data on semaglutide, liraglutide, and suicidality. JAMA Netw Open 7(8):e2423385","journal-title":"JAMA Netw Open"},{"key":"938_CR37","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/35007534","volume":"404","author":"MW Schwartz","year":"2000","unstructured":"Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404:661\u2013671","journal-title":"Nature"},{"key":"938_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jhep.2019.10.006","volume":"72","author":"MS Siddiqui","year":"2019","unstructured":"Siddiqui MS, Van Natta ML, Connelly MA, Vuppalanchi R, Neuschwander-Tetri BA, Tonascia J, Guy C, Loomba R, Dasarathy S, Wattacheril J et al (2019) Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis. J Hepatol 72:25\u201333","journal-title":"J Hepatol"},{"key":"938_CR39","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","volume":"102","author":"CJ Sinal","year":"2000","unstructured":"Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ (2000) Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis. Cell 102:731\u2013744","journal-title":"Cell"},{"key":"938_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2026.178910","volume":"1025","author":"JZ Song","year":"2026","unstructured":"Song JZ, Wang Y, Guo RR, Wang K, Hu Y, Cui M, Wang GJ, Hao HP, Wang H, Xu XW (2026) Intestinal-restricted farnesoid X receptor agonist Fex3 alleviates cholestatic liver injury via FGF15-CYP7A1 axis. Eur J Pharm 1025:178910","journal-title":"Eur J Pharm"},{"key":"938_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107950","volume":"221","author":"A Stefela","year":"2025","unstructured":"Stefela A, Dohnalova K, Lastuvkova H, Skoda J, Bajnokova M, Lestavel S, Touche V, Kaspar M, Kudova E, Hroch M et al (2025) The farnesoid X receptor (FXR) antagonist 7\u03b2-isopropylchenodeoxycholic acid improves glucose metabolism in mice on a Western diet. Pharm Res 221:107950","journal-title":"Pharm Res"},{"key":"938_CR42","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s00259-023-06124-4","volume":"50","author":"L Sun","year":"2023","unstructured":"Sun L, Laurila S, Lahesmaa M, Rebelos E, Virtanen KA, Schnabl K, Klingenspor M, Nummenmaa L, Nuutila P (2023) Secretin modulates appetite via brown adipose tissue-brain axis. Eur J Nucl Med Mol Imaging 50:1597\u20131606","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"938_CR43","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41586-024-08108-2","volume":"636","author":"HL Tan","year":"2022","unstructured":"Tan HL, Yin L, Tan Y, Ivanov J, Plucinska K, Ilanges A, Herb BR, Wang P, Kosse C, Cohen P et al (2022) Leptin-activated hypothalamic BNC2 neurons acutely suppress food intake. Nature 636:198\u2013205","journal-title":"Nature"},{"key":"938_CR44","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/ijms26030950","volume":"26","author":"B Wang","year":"2025","unstructured":"Wang B, Tang N, Chen S, Zhang X, Chen D, Li Z, Zhou B (2025) Exploration of appetite regulation in Yangtze sturgeon (Acipenser dabryanus) during weaning. Int J Mol Sci 26:950","journal-title":"Int J Mol Sci"},{"key":"938_CR45","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ebiom.2018.10.028","volume":"37","author":"H Wang","year":"2018","unstructured":"Wang H, Ge C, Zhou J, Guo Y, Cui S, Huang N, Yan T, Cao L, Che Y, Zheng Q et al (2018a) Noncanonical farnesoid X receptor signaling inhibits apoptosis and impedes liver fibrosis. EBioMedicine 37:322\u2013333","journal-title":"EBioMedicine"},{"key":"938_CR46","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1080\/13543776.2018.1527906","volume":"28","author":"H Wang","year":"2018","unstructured":"Wang H, He Q, Wang G, Xu X, Hao H (2018b) FXR modulators for enterohepatic and metabolic diseases. Expert Opin Ther Pat 28:765\u2013782","journal-title":"Expert Opin Ther Pat"},{"key":"938_CR47","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1124\/dmd.114.061622","volume":"43","author":"H Wang","year":"2015","unstructured":"Wang H, Yan T, Xie Y, Zhao M, Che Y, Zhang J, Liu H, Cao L, Cheng X, Xie Y et al (2015) Mechanism-based inhibitory and peroxisome proliferator-activated receptor \u03b1-dependent modulating effects of silybin on principal hepatic drug-metabolizing enzymes. Drug Metab Dispos 43:444\u2013454","journal-title":"Drug Metab Dispos"},{"key":"938_CR48","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1016\/j.bmcl.2017.06.003","volume":"27","author":"H Wang","year":"2017","unstructured":"Wang H, Zhao Z, Zhou J, Guo Y, Wang G, Hao H, Xu X (2017) A novel intestinal-restricted FXR agonist. Bioorg Med Chem Lett 27:3386\u20133390","journal-title":"Bioorg Med Chem Lett"},{"key":"938_CR49","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/med.21991","volume":"44","author":"K Wang","year":"2024","unstructured":"Wang K, Zhang Y, Wang G, Hao H, Wang H (2024) FXR agonists for MASH therapy: Lessons and perspectives from obeticholic acid. Med Res Rev 44:568\u2013586","journal-title":"Med Res Rev"},{"key":"938_CR50","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3390\/nu13051536","volume":"13","author":"YB Wang","year":"2021","unstructured":"Wang YB, Shivappa N, H\u00e9bert JR, Page AJ, Gill TK, Melaku YA (2021) Association between dietary inflammatory index, dietary patterns, plant-based dietary index and the risk of obesity. Nutrients 13:1536","journal-title":"Nutrients"},{"key":"938_CR51","doi-asserted-by":"publisher","first-page":"10610","DOI":"10.3390\/ijms221910610","volume":"22","author":"D Wei","year":"2021","unstructured":"Wei D, Sun Q, Li Y, Li C, Li X, Sun C (2021) Leptin reduces plin5 m6A methylation through FTO to regulate lipolysis in piglets. Int J Mol Sci 22:10610","journal-title":"Int J Mol Sci"},{"key":"938_CR52","doi-asserted-by":"publisher","first-page":"7164","DOI":"10.1016\/j.cell.2024.10.001","volume":"187","author":"J Yang","year":"2024","unstructured":"Yang J, Zhao T, Fan J, Zou H, Lan G, Guo F, Shi Y, Ke H, Yu H, Yue Z et al (2024) Structure-guided discovery of bile acid derivatives for treating liver diseases without causing itch. Cell 187:7164\u20137182","journal-title":"Cell"},{"key":"938_CR53","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41586-026-10633-1","volume":"655","author":"Y Zang","year":"2026","unstructured":"Zang Y, Shi J, Zhao G, Tang B, Liu M, Yao B, Wang G, Pan H, Yang S, Deng R et al (2026) A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases. Nature 655:758\u2013768","journal-title":"Nature"},{"key":"938_CR54","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.cmet.2020.11.017","volume":"33","author":"X Zheng","year":"2020","unstructured":"Zheng X, Chen T, Jiang R, Zhao A, Wu Q, Kuang J, Sun D, Ren Z, Li M, Zhao M et al (2020) Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism. Cell Metab 33:791\u2013803","journal-title":"Cell Metab"},{"key":"938_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14138-6","volume":"11","author":"J Zhou","year":"2020","unstructured":"Zhou J, Cui S, He Q, Guo Y, Pan X, Zhang P, Huang N, Ge C, Wang G, Gonzalez FJ et al (2020) SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis. Nat Commun 11:240","journal-title":"Nat Commun"},{"key":"938_CR56","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.apsb.2018.11.004","volume":"9","author":"J Zhou","year":"2019","unstructured":"Zhou J, Huang N, Guo Y, Cui S, Ge C, He Q, Pan X, Wang G, Wang H, Hao H (2019) Combined obeticholic acid and apoptosis inhibitor treatment alleviates liver fibrosis. Acta Pharm Sin B 9:526\u2013536","journal-title":"Acta Pharm Sin B"},{"key":"938_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107862","volume":"218","author":"CY Zhu","year":"2025","unstructured":"Zhu CY, Yu PH, Sun Q, Hong DF, Yang C, Naranmandura H (2025) Nuclear receptors in metabolism and diseases: mechanistic and therapeutic insights. Pharm Res 218:107862","journal-title":"Pharm Res"},{"key":"938_CR58","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.phrs.2010.12.018","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Li F, Guo GL (2011) Tissue-specific function of farnesoid X receptor in liver and intestine. Pharm Res 63:259\u2013265","journal-title":"Pharm Res"}],"container-title":["EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-026-00938-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44319-026-00938-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-026-00938-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:05:58Z","timestamp":1791237958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44319-026-00938-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":58,"alternative-id":["938"],"URL":"https:\/\/doi.org\/10.1038\/s44319-026-00938-7","relation":{},"ISSN":["1469-3178"],"issn-type":[{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}